Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
German CLL Study Group
Memorial Sloan Kettering Cancer Center
Northwestern University
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Temple University